People use histidine as medicine. Some people take histidine by mouth for metabolic syndrome, diarrhea caused by cholera infection, rheumatoid arthritis, allergic diseases, ulcers, and anemia caused by kidney failure or kidney dialysis. How does it work? Histidine is involved in a wide range of metabolic processes in the body.
HistoGenetics is applying cutting-edge sequencing technologies to study all living species, helping lead innovation in human, plant, and animal research and precision medicine. Our pioneering work since our founding has led to SBT becoming the standard for HLA typing, making other methods obsolete for high-resolution HLA typing in donor recruitment and patient matching for blood stem cell transplantation …
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas Oncotarget. 2017 Dec 4 ... Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 14 Department of Otolaryngology, Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
histogenetic: (hĭs-tō-jĕn′ĕ-sĭs) [″ + genesis , generation, birth] The development into differentiated tissues of a germ layer; the origin and development of tissue. histogenetic (hĭs″tō-jĕ-nĕt′ĭk), adjective
52) were evaluated, and the histogenetic background was analyzed. All of the cases were sporadic GCs. For particular aspects, Maspin, E-cadherin, and SLUG immunostains were performed. For our final conclusions, the results were correlated with literature data. In early stages, poorly cohesive carcinomas can display 3 histogenetic pathways, with particular molecular behaviors: “carcinoma with ...
To identify the histogenetic pathways, the cases were first grouped in adenocarcinomas and poorly cohesive carcinomas that include signet-ring cell carcinomas (Table (Table1). 1). Then, a careful examination of the tumor architecture and immunohistochemical particularities of the tumor cells and normal peritumoral mucosa, performed by all 5 ...
Histogenetic type was the only factor which differentiated between 'thin' (= 0.8 mm) and 'thick' (> 2.0 mm) lesions. During a 10-year period only 3% of the nodular lesions were 'thin' at diagnosis. Differences in knowledge about melanoma or the location of the lesion (either 'easy' or 'difficult' for the patient to observe) did not explain ...
1888 -
Histogenetic Medicine:
The Seattle post-intelligencer. [volume] (Seattle, Wash. Terr. [Wash.]) 1888-1914, May 22, 1888, Image 2
Image provided by Washington State Library; Olympia, WA
No comments:
Post a Comment